Sort
82,697 grants matching “vaccine development”
Immune signatures of vaccine responses in vulnerable populations
$2,388,688Ruth R Montgomery · Yale University · U19 · FY2025 · AI
DENVER AUTOIMMUNITY CENTER OF EXCELLENCE
$2,387,669University Of Colorado Denver · U19 · FY2001 · AI
Units for HIV/AIDS Clinical Trials Networks
$2,387,394Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U01 · FY2008 · AI
A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum
$2,387,026Michael Anthony Moody · Duke University · U01 · FY2024 · AI
Epitope-targeted Vaccines for HIV-1 Prevention
$2,386,714Xiangpeng Kong · New York University School Of Medicine · P01 · FY2012 · AI
Harnessing natural killer cell memory to fight viruses
$2,386,599Catherine A Blish · Stanford University · DP2 · FY2013 · AI
Anti-viral immune responses in lymph node
$2,386,489Ulrich H Von Andrian · Harvard Medical School · P01 · FY2012 · AI
Center for the Study of Immune Mechanisms of Flavivirus Control
$2,385,627Michael J Gale · University Of Washington · U19 · FY2017 · AI
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery
$2,385,204Colleen B Jonsson · University Of Tennessee Health Sci Ctr · UC7 · FY2024 · AI
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,384,337David A Barbie · Dana-Farber Cancer Inst · P50 · FY2022 · CA
SPORE in Prostate Cancer
$2,383,257Peter T Scardino · Sloan-Kettering Inst Can Research · P50 · FY2006 · CA
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$2,382,602Myron E Essex · Harvard School Of Public Health · UM1 · FY2014 · AI
Pitt-Ohio State Clinical Trials Unit
$2,382,302Sharon Riddler · University Of Pittsburgh At Pittsburgh · UM1 · FY2025 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$2,382,232Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development
$2,381,998Celia Labranche · Duke University · N01 · FY2021 · AI
Development of a Nanoemulsion Adjuvant: HIV elective project
$2,381,521Ali I. Fattom · Bluewillow Biologics, Inc. · N01 · FY2016 · AI
A Gene therapeutic approach to stable suppression of HIV-1 replication
$2,381,501Michael R. Farzan · Scripps Florida · P01 · FY2016 · AI
Mechanisms of Immune Protection Against Respiratory Viruses
$2,380,350Ali Hassan Ellebedy · Washington University · U19 · FY2025 · AI
Mechanisms of Immune Protection Against Respiratory Viruses
$2,380,350Ali Hassan Ellebedy · Washington University · U19 · FY2024 · AI
Genetic Analysis of T-cell Differentiation
$2,380,130Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Influenza Vaccine Development
$2,378,449Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
A common denominator of pathogenesis; a rare opportunity for novel therapeutic de
$2,377,500Douglas Alan Mitchell · University Of Illinois At Urbana-Champaign · DP2 · FY2011 · OD
Adeno-associated Virus Biology And Utilization For Gene Transfer
$2,377,221John A Chiorini · National Institute Of Dental & Craniofacial Research · ZIA · FY2012 · DE
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
$2,377,023Steven Foung · Stanford University · U19 · FY2021 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$2,376,660Valerie Fremont · Quality Biological, Inc. · N01 · FY2018 · AI